Sandrine Verpoorten
About Sandrine Verpoorten
Sandrine Verpoorten is a medical scientist specializing in oncology and cell therapy. She has an extensive academic background in molecular medicine and has held various positions in medical affairs and research across multiple organizations.
Work at Kite Pharma
Sandrine Verpoorten has been employed at Kite Pharma since 2021, serving as a Medical Scientist and Medical Science Liaison (MSL) specializing in Oncology and Cell Therapy. In this role, she contributes to the development and implementation of scientific strategies that support Kite's innovative therapies. Her responsibilities include engaging with healthcare professionals to provide insights into the clinical data and therapeutic applications of Kite's products.
Education and Expertise
Sandrine Verpoorten holds a Master's degree in Molecular Medicine from Eberhard-Karls-Universität Tübingen, where she studied from 2012 to 2014. She also completed her Bachelor's degree in Molecular Medicine at the same institution from 2008 to 2012. Additionally, she earned a Doctor of Philosophy (PhD) in Medical Science from Hull York Medical School, studying from 2016 to 2019. Her academic background is complemented by a term abroad scholarship at the University of Utrecht during her BSc studies.
Background
Sandrine Verpoorten's professional journey includes significant roles in the medical and pharmaceutical sectors. Prior to her current position at Kite Pharma, she worked as a Medical Affairs professional at Amgen for four months in 2019 and served as a Medical Manager at Bionorica SE from 2019 to 2021. Her experience as a PhD student at Hull York Medical School from 2016 to 2019 further solidified her expertise in medical science and research.
Achievements
During her academic career, Sandrine Verpoorten completed a joint Master's project with ERBE Medical UK Ltd, which contributed to her practical experience in the field of Molecular Medicine. Her scholarship at the University of Utrecht highlights her commitment to expanding her knowledge and skills in medical science. These experiences have shaped her current role in oncology and cell therapy at Kite Pharma.